| Literature DB >> 35847863 |
Shenglin Xu1, Zehao Guo1, Qiling Shen1, Yongjun Peng1, Jian Li1, Sheng Li1, Peng He1, Zheng Jiang1, Yukang Que1, Kun Cao1, Bo Hu1, Yong Hu1.
Abstract
Background: Reconstruction of pelvis girdle stability after tumor-induced hemipelvectomy remains challenging. We surgically treated 13 patients with custom-made, three-dimensional printed hemipelvic prostheses. We aim to identify the preliminary outcomes for patients who have been managed with more mixed regions of prosthetic pelvic reconstruction and the feasibility of two reconstructive systems.Entities:
Keywords: 3D printing; endoprosthesis; hemipelvic reconstruction; pelvic tumor; porous
Year: 2022 PMID: 35847863 PMCID: PMC9282862 DOI: 10.3389/fonc.2022.935059
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Demographics, complications, and outcomes of the patients.
| Patient number | Gender | Age (years) | Pathological diagnoses | Resection classification | Surgery duration (min) | Blood loss (ml) | Additional surgery | Complications | Follow-up (months) | Status | MSTS-93 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Female | 52 | CS | II + III | 245 | 2,764 | Amputation | 11 | NED | 25 | |
| 2 | Female | 52 | CS | I + II | 345 | 1,973 | 23 | AWD | 26 | ||
| 3 | Male | 57 | CS | I + II | 410 | 2,857 | 36 | NED | 25 | ||
| 4 | Male | 69 | CS | I + II | 375 | 3,363 | Dislocation | 20 | NED | 21 | |
| 5 | Male | 43 | OS | I + II | 480 | 2,932 | 28 | AWD | 22 | ||
| 6 | Male | 75 | OS | I + II + III | 660 | 3,923 | Cystostomy + DJUS implantation | 28 | NED | 16 | |
| 7 | Female | 54 | Renal cell cancer | I + II + III | 320 | 2,907 | 37 | AWD | 26 | ||
| 8 | Male | 66 | Prostate cancer | I + II + III | 300 | 2,370 | 12 | AWD | 26 | ||
| 9 | Female | 55 | CS | I + II + III | 510 | 3,215 | DWH | 14 | NED | 16 | |
| 10 | Male | 53 | CS | I + II + III | 620 | 3,333 | Prosthesis-preserving tumor resection | 14 | NED | 23 | |
| 11 | Female | 53 | CS | I + II + III | 600 | 3,098 | 20 | NED | 17 | ||
| 12 | Female | 50 | CS | I + II + III | 660 | 4,657 | DWH | 21 | NED | 22 | |
| 13 | Male | 32 | OS | I + II + III | 540 | 3,150 | 27 | DOD | 22 |
CS, chondrosarcoma; OS, osteosarcoma; DJUS, double-J ureteral stent; DWH, delayed wound healing; NED, no evidence of disease; AWD, alive with disease; DOD, died of disease.
Figure 1A 53-year-old female patient with chondrosarcoma. (A) Preoperative MRI showed the invasion of the sacroiliac joint. (B) The design of Type A prosthesis (green part: porous structure; blue part: solid structure). (C) The 3D-printed prosthesis with lattice bone contact surface. (D) Intraoperative installation of patient-specific drill guide at the auricular surface. (E) Installation of 3D-printed prosthesis. (F) Immediate x-ray after surgery showed that the prosthesis was fitted precisely.
Figure 2A 66-year-old male patient with metastatic prostate cancer. (A) The design of type B prosthesis after partial type I + II + III resection (green part: porous structure; blue part: solid structure). (B) The real picture of the implant. (C) Intraoperative installation of patient-specific osteotomy guide on the iliac crest. (D) Extra-articular resection of the tumor. (E) Postoperative x-ray manifested promising accuracy of the prosthesis.
Figure 3A 52-year-old female patient with recurrent chondrosarcoma 11 months after prosthetic implantation. (A) Type B prosthesis after type II + III resection. (B) Postoperative x-ray showed excellent shape compatibility. (C) The gross specimen of the affected hemipelvis. (D) The cross section showed the osseointegration ability of the porous structure. (E) Fibrous tissue could extend to the 3D-printed macro pores.
Comparison of the 3D-printed, custom-made hemipelvic prosthetic reconstruction studies.
| Year | Author | Resection classification | Case number | Follow-up (months) | MSTS-93 | Complications | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| DWH | IF | DL | HT | |||||||
| Current study | II + III | 1 | 22.4 (11–37) | 22.0 (16–26) | 2 | 1 | ||||
| 2017 | Wang ( | Including II | 11 | 15.5 (6–44) | 19.2 (13–25) | 1 | 2 | |||
| 2020 | Wang ( | I + II | 3 | 27.3 (24–31) | Median 23 (15–27) | 2 | ||||
| 2021 | Peng ( | I + II | 2 | 19.8 (15–26) | 19.8 (15–26) | None | ||||
| 2021 | Xu ( | I | 5 | 11.9 (6–24) | 23.8 | NA | ||||
| 2021 | Pu ( | I | 12 | Median 21 | 24.1 | 1 | ||||
DWH, delayed wound healing; IF, infection; DL, dislocation; HT, hematoma; NA, not available.